IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin

These data reveal a hitherto unrecognized role of mTOR signaling in IL-33-driven, ILC-dependent inflammation in vivo and suggest that manipulation of this pathway might represent a target for therapeutic intervention for airway inflammation.